CSIR_IPU

Innovation Protection Unit (IPU) is a Central Unit providing IP related services to all Labs of Council of Scientific and Industrial Research (CSIR).

[CSIR_IPU @CsirIpu]

This will help in increasing the reliability and predictability of future AI patents in the US and for other countries to learn from. @ravboc, @Dr_Rahul_Mishra,
The Real Reason Why America Is Inviting Public Comments On AI Patents https://t.co/jDmppxttD6 via @Analyticsindiam

[CSIR_IPU @CsirIpu]

Indirectly targeting the oncogene MYC by blocking the protein ATF4 may offer a new strategy for treating several cancers. @ravboc, @Dr_Rahul_Mishra, @IGIB_DEL_110007, @ccmb_csir, @CSIR_CDRI

https://t.co/E9uWd3ion2

[CSIR_IPU @CsirIpu]

Artificial intelligence (AI): A detailed report from WIPO. Includes projections and latest trends in AI based on the analysis of patents and scientific publications. @ravboc @CSIRCEERI @CSIR_CSIO @csirngri @Dr_Rahul_Mishra
https://t.co/rbch7R8fxr
https://t.co/qONvuYLtqv

[CSIR_IPU @CsirIpu]

Better therapies are desperately needed for Sickle Cell Disease (SCD). @ravboc, @dr_rahul_mishra
The FDA Encourages New Treatments for Sickle Cell Disease https://t.co/it1ne6nF0a

[CSIR_IPU @CsirIpu]

China claims more patents than any country—most are worthless. @ravboc, dr-rahul_mishra
https://t.co/FNx3Tl5yWE via @technology

[CSIR_IPU @CsirIpu]

#PLOSONE: Indian pharmaceutical patent prosecution: The changing role of Section 3(d) @ravboc, @dr_rahul_mishra https://t.co/Rpwlz3t5P1

[CSIR_IPU @CsirIpu]

Patents for Combination Products: Challenges and Opportunities – DrugPatentWatch - Make Better Decisions. @ravboc; @dr_rahul_mishra https://t.co/7eT7kAWZcB

[CSIR_IPU @CsirIpu]

Big Pharma Is Synthesizing Cannabis To Make A Patent-able Pill. @ravboc, @dr_rahul_mishra
https://t.co/Oba98jScIO via @USA Health Times